SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-18-000017
Filing Date
2018-03-22
Accepted
2018-03-22 16:09:09
Documents
10
Period of Report
2017-12-31
Effectiveness Date
2018-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY haloproxy2018.htm DEF 14A 1081686
2 halologobwa02.jpg GRAPHIC 38428
3 htsignaturea03.jpg GRAPHIC 31598
4 leonhardtsignature2a02.jpg GRAPHIC 413112
5 proxycardv3page1a01.jpg GRAPHIC 300301
6 proxycardv3page2a01.jpg GRAPHIC 225543
7 slide1a53.jpg GRAPHIC 56916
8 slide2a42.jpg GRAPHIC 58047
9 slide3a44.jpg GRAPHIC 61847
10 slide4a02.jpg GRAPHIC 56939
  Complete submission text file 0001159036-18-000017.txt   2757293
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 18707029
SIC: 2836 Biological Products, (No Diagnostic Substances)